The US pharmaceutical industry should brace itself for change as Americans become more involved in choosing their own prescription drugs.
Ads by Google
The first initiative to be undertaken by ACI and Sanovia will be to develop a library of evidence- based guidelines for the appropriate use of high-cost pharmaceuticals and biotech products.
Over one hundred Long Island AARP members gathered to rally state lawmakers to pass legislation before the end of the 2007 Legislative Session in Albany that will help make prescription drugs more affordable and help assure that their cell phone works in an emergency.
U.S. Food and Drug Administration will accept either a positive interim or final analysis of survival from its ongoing IMPACT study to amend the Biologics License Application for PROVENGE (sipuleucel-T).
U.S. Food and Drug Administration has approved the New Drug Application of Critical Therapeutics for ZYFLO CR extended-release tablets.
Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration for its supplemental Abbreviated New Drug Application for Fluoxetine Capsules USP, 40 mg.
Laboratorios Kimiceg has selected Epicor for Pharmaceutical to integrate its manufacturing and financial processes.
A new study found RADAR identified serious drug reactions six years earlier than the FDA and drug companies.
Hong Kong Department of Health called on members of the public not to buy or use a brand of health product called Heng Tong Jiangtangning Jiaonang.
The U.S. Food and Drug Administration to take action against companies that market unapproved drug products in timed-release dosage form that contain guaifenesin.
Orphan drug designation granted by the U.S. Food and Drug Administration to Cyclosporine A drug Vekacia, a patented cationic emulsion, for the treatment of Vernal Keratoconjunctivitis.
The high costs of prescription drugs led many Hispanics and African Americans to take desperate measures, like delaying filling a prescription or skipping doses.
The Institute for OneWorld Health has first approved drug product, Paromomycin IM Injection, was designated by the World Health Organization for inclusion on its Model List for Essential Medicines.
Nuvion, an antibody in development as a treatment for intravenous steroid-refractory ulcerative colitis, administered on day 1 and day 2, produced a sustained clinical response up to 310 days and was adequately tolerated.
Nearly nine out of ten patients taking once-daily LIALDA remained relapse free at the end of 12 months.
KV Pharmaceutical Company has received final approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application to market its 100 mg and 200 mg strengths of metoprolol succinate extended-release tablets.
Abbott will present new data from its SPIRIT family of clinical trials studying the XIENCE V Everolimus Eluting Coronary Stent System, and the ABSORB trial of the world's first fully bioabsorbable drug-eluting coronary stent.
"A Dialogue: Seeking Common Ground On Drug Safety" launches a new series of forums to address policy issues related to the anticipated passage and implementation of the Food & Drug Administration Revitalization Act.
Northern Ireland Health Minister reviews the unfair system where some people are charged for their medicines.
Wolters Kluwer Health released findings on the market impact of the Medicare Part D prescription drug program's first year.
Health Canada is advising consumers not to use Xiaokeshuping Jiangtangning Jiaonang capsules due to concerns about possible side-effects.
Medicare proposed decision to limit coverage of erythropoiesis stimulating agent (ESA) treatment for beneficiaries with certain cancers and related neoplastic conditions, either because of a deleterious effect of the ESA on the beneficiaries' underlying disease or because the underlying disease increases their risk of adverse effects related to ESA use.
Sales of over-the-counter allergy medications have doubled in the past week - one indication that spring allergy season is here.
Health Canada is warning patients taking the anti-epilepsy medications Depakene 500 mg and ratio-VALPROIC 500 mg that they may not be getting the full dose of the active drug, which could result in inadequate treatment of their seizures.
Barr Pharmaceuticals announced that its subsidiary has received tentative approval from the U.S. Food and Drug Administration for its generic version of Janssen Pharmaceutica Products, L.P.'s Razadyne (Galantamine Hydrobromide), 4mg, 8mg and 12mg Tablets.
The United States Senate overwhelmingly passed significant prescription drug safety reforms to give FDA more power to deal with unsafe medicines on the market. Being the first significant drug safety measure in 45 years, the House is urged to pass a strong prescription drug safety bill.